Contact
searchSearch
HMP Global
Quiz

Trivia: Internalized Skin Bias in HS

Jessica Garlewicz
05/17/2022

Related Content

Insights
Expanding the HS Treatment Landscape: From Single-Pathway Therapy to Personalized Care
06/08/2026
Leandra A. Barnes, MD, FAAD; Jessica Garlewicz
A developing pipeline is shifting care toward individualized, multi-pathway approaches while highlighting ongoing gaps in treatment expectations and patient access.
A developing pipeline is shifting care toward individualized, multi-pathway approaches while highlighting ongoing gaps in treatment expectations and patient access.
A developing pipeline is...
06/08/2026
The Dermatologist
James Krueger, MD, PhD
Conference Coverage
HS Immunopathogenesis Drives Expansion of Targeted Therapeutic Strategies
05/15/2026
Jessica Garlewicz
Hidradenitis suppurativa represents one of the most immunologically complex inflammatory skin diseases, with emerging insights into its pathogenesis reshaping the therapeutic landscape.
Hidradenitis suppurativa represents one of the most immunologically complex inflammatory skin diseases, with emerging insights into its pathogenesis reshaping the therapeutic landscape.
Hidradenitis suppurativa...
05/15/2026
The Dermatologist
Videos
Hidradenitis Suppurativa: Early Recognition, IL-17 Targeted Therapies, and Multidisciplinary Care
04/01/2026
Riya Gandhi, MA
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how...
04/01/2026
The Dermatologist
News
Emerging JAK1 and C5a Inhibitors Show Promise in Hidradenitis Suppurativa Network Meta-Analysis
03/31/2026
Riya Gandhi, MA
Comparative data highlight improved efficacy and tolerability signals with investigational therapies vs current standards.
Comparative data highlight improved efficacy and tolerability signals with investigational therapies vs current standards.
Comparative data highlight...
03/31/2026
The Dermatologist

Popular Articles

psoriasis
News
Long-Term Risankizumab Treatment for Moderate to Severe Plaque Psoriasis
08/22/2024
Jessica Garlewicz
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the long-term efficacy of risankizumab for moderate to severe plaque psoriasis.
Researchers assessed the...
08/22/2024
The Dermatologist
Case Report
Successful Treatment of Melasma in Fitzpatrick Skin Type IV
10/07/2024
Monica Khadka, BA, BS; Kerry C. Hennessy, MD; Lilia M. Correa-Selm, MD, FAAD
Nonablative Alexandrite laser therapy may be an effective method of treating melasma in patients with darker skin types.
Nonablative Alexandrite laser therapy may be an effective method of treating melasma in patients with darker skin types.
Nonablative Alexandrite laser...
10/07/2024
The Dermatologist
psoriasis
News
Overlap Phenotype Between Psoriasis and Atopic Dermatitis
07/18/2024
Jessica Garlewicz
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene...
07/18/2024
The Dermatologist
Clinical Tips
Individualizing Botulinum Toxin Dosage
09/06/2024
Benjamin Barankin, MD, FRCPC
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from...
09/06/2024
The Dermatologist
NPF Endorsed Features
Phone-a-Friend: Exploring the Collaborative Care Model in Psoriasis
08/06/2024
Samantha Koons
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of...
08/06/2024
The Dermatologist
June 2026 issue

Current Issue

June 2026
Volume 34
Issue 4
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use